American Peptide Company, Inc. (APC) offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide Active Pharmaceutical Ingredients.
Our California based manufacturing facilities offer synthesis services under Non GMP (Sunnyvale, California) and cGMP (Vista, California) conditions.
Our cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A.
Our Total Peptide Management services support clients in the drug development process from pre-clinical through commercial stage.
Our value added services include process development, scale up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.
A nonapeptide capable of inhibiting the conversion of angiotensin I to angiotensin II, in vitro and in vivo. Bradykinin Potentiator
Angiotensin I Converting Enzyme Substrate